The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling

被引:38
作者
Hibbs, Margaret L. [1 ]
Harder, Kenneth W. [1 ]
机构
[1] Royal Melbourne Hosp, Melbourne Tumour Biol Branch, Ludwig Inst Canc Res, Tumour Biol Branch, Melbourne, Vic 3050, Australia
基金
英国医学研究理事会;
关键词
Src family kinase; signal transduction; negative regulation of signaling; growth factor signaling; leukemia;
D O I
10.1080/08977190600581327
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Lyn tyrosine kinase is a unique member of the Src family of non-receptor protein tyrosine kinases whose principal role is to regulate signals through inhibitory receptors thereby promoting signal attenuation. Lyn is renowned for its role in B cell antigen receptor and Fc epsilon RI signaling; however, it is becoming increasingly apparent that Lyn also functions in signal transduction from growth factor receptors including the receptors for GM-CSF, IL-3, IL-5, SCF, erythropoietin, CSF-1, G-CSF, thrombopoietin and Flt3 ligand. Numerous studies have implicated Lyn in growth factor receptor signal amplification, while a number also suggest that Lyn participates in negative regulation of growth factor signaling. Indeed Lyn-deficient mice are hyper-responsive to myeloid growth factors and develop a myeloproliferative disorder that predisposes the mice to macrophage tumours, with loss of negative regulation through SHP-1 and SHIP-1 thought to be the major contributing factor to this phenotype. Developing a clear understanding of Lyn's role in establishing signaling thresholds in growth factor receptor signal amplification and signal inhibition may have important implications in the management of leukemias that may depend on Lyn activity.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 120 条
  • [1] Adachi T, 1999, J IMMUNOL, V162, P1496
  • [2] Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development
    Agosti, V
    Corbacioglu, S
    Ehlers, I
    Waskow, C
    Sommer, G
    Berrozpe, G
    Kissel, H
    Tucker, CM
    Manova, K
    Moore, MAS
    Rodewald, HR
    Besmer, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) : 867 - 878
  • [3] SEQUENCE REQUIREMENTS FOR BINDING OF SRC FAMILY TYROSINE KINASES TO ACTIVATED GROWTH-FACTOR RECEPTORS
    ALONSO, G
    KOEGL, M
    MAZURENKO, N
    COURTNEIDGE, SA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) : 9840 - 9848
  • [4] ANDERSON SM, 1995, J IMMUNOL, V155, P1660
  • [5] CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling
    Arai, A
    Kanda, E
    Nosaka, Y
    Miyasaka, N
    Miura, O
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) : 33282 - 33290
  • [6] Regulation of mast cell survival by IgE
    Asai, K
    Kitaura, J
    Kawakami, Y
    Yamagata, N
    Tsai, M
    Carbone, DP
    Liu, FT
    Galli, SJ
    Kawakami, T
    [J]. IMMUNITY, 2001, 14 (06) : 791 - 800
  • [7] The inositol 5′-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity
    Baran, CP
    Tridandapani, S
    Helgason, CD
    Humphries, RK
    Krystal, G
    Marsh, CB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) : 38628 - 38636
  • [8] Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity
    Beavitt, SJE
    Harder, KW
    Kemp, JM
    Jones, J
    Quilici, C
    Casagranda, F
    Lam, E
    Turner, D
    Brennan, S
    Sly, PD
    Tarlinton, DM
    Anderson, GP
    Hibbs, ML
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (03) : 1867 - 1875
  • [9] Oncogenic kinase signalling
    Blume-Jensen, P
    Hunter, T
    [J]. NATURE, 2001, 411 (6835) : 355 - 365
  • [10] Regulation, substrates and functions of src
    Brown, MT
    Cooper, JA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 121 - 149